| Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells F Ghasemi, M Shafiee, Z Banikazemi, MH Pourhanifeh, H Khanbabaei, ... Pathology-Research and Practice 215 (10), 152556, 2019 | 233 | 2019 |
| Curcumin delivery mediated by bio-based nanoparticles: a review M Moballegh Nasery, B Abadi, D Poormoghadam, A Zarrabi, P Keyhanvar, ... Molecules 25 (3), 689, 2020 | 201 | 2020 |
| Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics M Ashrafizadeh, Z Ahmadi, N Mohamadi, A Zarrabi, S Abasi, ... International journal of biological macromolecules 145, 282-300, 2020 | 100 | 2020 |
| Autophagy modulators: mechanistic aspects and drug delivery systems S Tavakol, M Ashrafizadeh, S Deng, M Azarian, A Abdoli, M Motavaf, ... Biomolecules 9 (10), 530, 2019 | 76 | 2019 |
| Circular RNA and diabetes: epigenetic regulator with diagnostic role K Abbaszadeh-Goudarzi, S Radbakhsh, MH Pourhanifeh, H Khanbabaei, ... Current molecular medicine 20 (7), 516-526, 2020 | 57 | 2020 |
| Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance R Shafabakhsh, F Arianfar, M Vosough, HR Mirzaei, M Mahjoubin-Tehran, ... Cancer Gene Therapy 28 (12), 1229-1255, 2021 | 43 | 2021 |
| Bismuth‐based nanomaterials: Recent advances in tumor targeting and synergistic cancer therapy techniques S Badrigilan, J Choupani, H Khanbabaei, M Hoseini‐Ghahfarokhi, ... Advanced Healthcare Materials 9 (7), 1901695, 2020 | 42 | 2020 |
| New epigenetic players in stroke pathogenesis: from non-coding RNAs to exosomal non-coding RNAs M Mahjoubin-Tehran, S Rezaei, A Jesmani, N Birang, K Morshedi, ... Biomedicine & Pharmacotherapy 140, 111753, 2021 | 36 | 2021 |
| An update on enterovirus 71 infection and interferon type I response M Rasti, H Khanbabaei, A Teimoori Reviews in medical virology 29 (1), e2016, 2019 | 34 | 2019 |
| The interplay between microRNAs and Twist1 transcription factor: a systematic review H Khanbabaei, A Teimoori, M Mohammadi Tumor Biology 37 (6), 7007-7019, 2016 | 34 | 2016 |
| Curcumin: a dietary phytochemical for targeting the phenotype and function of dendritic cells K Rahimi, K Hassanzadeh, H Khanbabaei, SM Haftcheshmeh, A Ahmadi, ... Current medicinal chemistry 28 (8), 1549-1564, 2021 | 33 | 2021 |
| Vitamin D receptor ApaI (rs7975232), BsmI (rs1544410), Fok1 (rs2228570), and TaqI (rs731236) gene polymorphisms and susceptibility to pulmonary tuberculosis in an Iranian … A Mohammadi, H Khanbabaei, R Nasiri-Kalmarzi, F Khademi, M Jafari, ... Journal of Microbiology, Immunology and Infection 53 (6), 827-835, 2020 | 33 | 2020 |
| Fractionated radiotherapy might induce epithelial‐mesenchymal transition and radioresistance in a cellular context manner MJ Tahmasebi‐Birgani, A Teimoori, A Ghadiri, H Mansoury‐Asl, ... Journal of cellular biochemistry 120 (5), 8601-8610, 2019 | 27 | 2019 |
| Vitamin D receptor genetic polymorphisms and the risk of multiple sclerosis: A systematic review and meta-analysis A Mohammadi, A Azarnezhad, H Khanbabaei, E Izadpanah, ... Steroids 158, 108615, 2020 | 26 | 2020 |
| Therapeutic potential of the miRNA–ATM axis in the management of tumor radioresistance AH Rezaeian, H Khanbabaei, GA Calin Cancer Research 80 (2), 139-150, 2020 | 26 | 2020 |
| microRNAs: Potential glioblastoma radiosensitizer by targeting radiation-related molecular pathways MT Bahreyni-Toossi, E Dolat, H Khanbabaei, N Zafari, H Azimian Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 816 …, 2019 | 26 | 2019 |
| Harnessing CRISPR/Cas 9 System for manipulation of DNA virus genome S Ebrahimi, A Teimoori, H Khanbabaei, M Tabasi Reviews in Medical Virology 29 (1), e2009, 2019 | 25 | 2019 |
| Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications H Khanbabaei, S Ebrahimi, JL García-Rodríguez, Z Ghasemi, ... Journal of Experimental & Clinical Cancer Research 41 (1), 278, 2022 | 24 | 2022 |
| Targeted delivery of CRISPR/Cas13 as a promising therapeutic approach to treat SARS-CoV-2 K Abbaszadeh-Goudarzi, MH Nematollahi, H Khanbabaei, HH Nave, ... Current pharmaceutical biotechnology 22 (9), 1149-1155, 2021 | 19 | 2021 |
| CRISPR-Cas system: a promising diagnostic tool for COVID-19 S Ebrahimi, H Khanbabaei, S Abbasi, M Fani, S Soltani, M Zandi, ... Avicenna journal of medical biotechnology 14 (1), 3, 2022 | 18 | 2022 |
